SOMRS
ALXN

State of Michigan Retirement System’s Alexion Pharmaceuticals ALXN Stock Holding History

State of Michigan Retirement System’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-57,961
Closed -$10.6M – 996
2021
Q2 		$10.6M Buy
57,961
+300
+0.5% +$51.5K 0.06% 249
2021
Q1 		$8.82M Buy
57,661
+100
+0.2% +$15.5K 0.06% 267
2020
Q4 		$8.99M Sell
57,561
-700
-1% -$90K 0.06% 245
2020
Q3 		$6.67M Buy
58,261
+1,900
+3% +$205K 0.05% 268
2020
Q2 		$6.33M Sell
56,361
-210,317
-79% -$22.3M 0.06% 253
2020
Q1 		$23.9M Sell
266,678
-2,800
-1% -$275K 0.26% 99
2019
Q4 		$29.1M Sell
269,478
-400
-0.1% -$42.8K 0.24% 109
2019
Q3 		$26.4M Buy
269,878
+40,200
+18% +$4.53M 0.24% 102
2019
Q2 		$30.1M Sell
229,678
-10,700
-4% -$1.38M 0.27% 89
2019
Q1 		$32.5M Buy
240,378
+500
+0.2% +$62.2K 0.26% 90
2018
Q4 		$23.4M Sell
239,878
-126,500
-35% -$15M 0.21% 107
2018
Q3 		$50.9M Buy
366,378
+500
+0.1% +$62.7K 0.37% 62
2018
Q2 		$45.4M Buy
365,878
+600
+0.2% +$70.1K 0.36% 61
2018
Q1 		$40.7M Sell
365,278
-200
-0.1% -$23.9K 0.33% 71
2017
Q4 		$43.7M Sell
365,478
-2,200
-0.6% -$268K 0.34% 68
2017
Q3 		$51.6M Sell
367,678
-6,100
-2% -$829K 0.42% 58
2017
Q2 		$45.5M Buy
373,778
+100,000
+37% +$11.6M 0.34% 64
2017
Q1 		$33.2M Buy
273,778
+20,400
+8% +$2.63M 0.26% 83
2016
Q4 		$31M Buy
253,378
+175,104
+224% +$21.4M 0.25% 82
2016
Q3 		$9.59M Buy
78,274
+500
+0.6% +$64.4K 0.08% 218
2016
Q2 		$9.08M Buy
77,774
+200
+0.3% +$28.4K 0.07% 219
2016
Q1 		$10.8M Buy
77,574
+500
+0.6% +$73.4K 0.09% 182
2015
Q4 		$14.7M Sell
77,074
-4,500
-6% -$786K 0.11% 151
2015
Q3 		$12.8M Sell
81,574
-5,300
-6% -$967K 0.1% 166
2015
Q2 		$15.7M Buy
86,874
+8,900
+11% +$1.54M 0.11% 155
2015
Q1 		$13.5M Sell
77,974
-3,700
-5% -$670K 0.09% 177
2014
Q4 		$15.1M Buy
81,674
+600
+0.7% +$111K 0.1% 168
2014
Q3 		$13.4M Hold
81,074
– – 0.09% 184
2014
Q2 		$12.7M Buy
81,074
+300
+0.4% +$47.4K 0.09% 198
2014
Q1 		$12.3M Buy
80,774
+1,100
+1% +$175K 0.09% 187
2013
Q4 		$10.6M Buy
79,674
+100
+0.1% +$12K 0.08% 202
2013
Q3 		$9.24M Buy
79,574
+300
+0.4% +$32.9K 0.08% 217
2013
Q2 		$7.31M Buy
+79,274
New +$7.64M 0.07% 244

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

State of Michigan Retirement System's ALXN Position: Q3 2021 in Review

State of Michigan Retirement System sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 57,961 shares — an estimated $10.6M sold.

State of Michigan Retirement System first reported a position in ALXN in Q2 2013 and held it in 33 quarters. The position peaked at $51.6M in Q3 2017. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • State of Michigan Retirement System reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • State of Michigan Retirement System sold 57,961 Alexion Pharmaceuticals shares in Q3 2021, an estimated $10.6M.
  • State of Michigan Retirement System first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 33 quarters.
  • State of Michigan Retirement System's Alexion Pharmaceuticals position peaked at $51.6M in Q3 2017.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on State of Michigan Retirement System's 13F filing for Q3 2021, filed 27 Oct 2021.